Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Destiny J West

3PUBLICATIONS

44CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 18, 2026

Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.

|Feb 24, 2025

Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma.

Miya B Hugaboom, Lena V Wirth, Kelly Street

|Dec 07, 2023

PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.

Thomas Denize, Opeyemi A Jegede, Sayed Matar

Pageof 1

Frequent Collaborators

3 joint publications

Thomas Denize

3 joint publications

Opeyemi A Jegede

3 joint publications

Sayed Matar

3 joint publications

Nourhan El Ahmar

3 joint publications

David F McDermott

3 joint publications

Varunika Savla

3 joint publications

Toni K Choueiri

3 joint publications

Michael B Atkins

3 joint publications

Sabina Signoretti

3 joint publications

David A Braun

Frequent Collaborators

3 joint publications

Thomas Denize

3 joint publications

Opeyemi A Jegede

3 joint publications

Sayed Matar

3 joint publications

Nourhan El Ahmar